Target intelligence / Profile preview

Leucine rich repeat containing 34 pseudogene 2 (LRRC34P2)

Target
LRRC34P2
Molecular classification
Other (Processed pseudogene)
01

Overview

Leucine rich repeat containing 34 pseudogene 2 (LRRC34P2) is a processed pseudogene, meaning it is a non-protein-coding sequence in the genome derived from the retrotransposition of mRNA of the parental gene LRRC34[1]. Processed pseudogenes like LRRC34P2 typically do not code for functional proteins and are generally not considered valid therapeutic or pharmacological targets[3][1]. While some pseudogenes have gained new regulatory or RNA-based functions, there is no specific functional or disease-related evidence for LRRC34P2[1][3]. The gene is present in several primate species but not in humans under this designation[1]. Thus, LRRC34P2 is not a biologically relevant molecular target in the classical sense of receptors, enzymes, or transporters, but instead is classified as a pseudogene[4][1].

Other names
LRRC34P2
02

Biological functions

Other (No known protein-coding or direct biological activity; typical for pseudogenes)
03

Disease associations

Other (Pseudogenes can play indirect roles in gene regulation and have been implicated in diseases through regulatory RNA mechanisms, but there is no direct evidence for this specific pseudogene)

Beyond the preview

Go deeper on Leucine rich repeat containing 34 pseudogene 2 (LRRC34P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine rich repeat containing 34 pseudogene 2 (LRRC34P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call